ProPhase Labs (PRPH)

• Market cap: $9.31M
• 1 day: -3.47%
• 5 days: -22.00%
• 1 month: -6.50%
• 3 months: -55.68%
• 6 months: -83.75%
• Year to date: -55.68%
• 1 year: -94.34%
• 5 years: -78.33%
• 10 years: -71.32%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.

Employees: 113

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

11% more funds holding

Funds holding: 27 [Q3] → 30 (+3) [Q4]

0.94% more ownership

Funds ownership: 9.19% [Q3] → 10.13% (+0.94%) [Q4]

55% less capital invested

Capital invested by funds: $4.24M [Q3] → $1.91M (-$2.32M) [Q4]